Signals Connect
Accelerating Insights: Efficient Data Querying and SAR Analysis with Signals Research Suite
Discover how the Signals Research Suite can streamline your data querying and analysis processes for more impactful structure activity relationship (SAR) analyses. This webinar will highlight the new search and summary tool, including how it can supplement existing decision-making visualizations. While centered on small molecule drug discovery, the insights shared will be valuable for diverse fields and industries.
Accelerating Insights: Efficient Data Querying and SAR Analysis with Signals Research Suite
Discover how the Signals Research Suite can streamline your data querying and analysis processes for more impactful structure activity relationship (SAR) analyses. This webinar will highlight the new search and summary tool, including how it can supplement existing decision-making visualizations. While centered on small molecule drug discovery, the insights shared will be valuable for diverse fields and industries.
Signals Research Suite Speakers
Samantha Jeschonek, Ph.D.
Product Manager Signals Research Suite, Revvity
Is the product manager for Data-driven Analytics in Signals Research Suite, Lead Discovery Premium, and Lead Discovery. She holds a Ph.D. in Molecular Biology, Cell Biology, and Biochemistry. She has spent the last several years as a product manager for drug discovery informatics software. In addition to more than a decade of bench experience in molecular biology, she brings a passion for FAIR data / metadata to the Revvity Signals product team.
Signals Notebook Connect: Celebrating a Year of Advancements and Looking Ahead
Join us for Signals Notebook Connect as we review a year of advancements and preview what's next. This webinar covers key 2024 updates, including enhanced collaboration tools and advanced data analytics. Field Application Scientist Marie Jue will demonstrate real-world applications, showing how these features streamline workflows and improve data integrity. Participate in an interactive Q&A with experts and get an exclusive preview of exciting AI-driven innovations planned for 2025. Whether new or experienced, this session offers valuable insights for maximizing Signals Notebook's potential.
Wednesday, November 6th - 8AM PST | 11AM EST | 5PM CET
Register now and secure your spot! We look forward to seeing you there!
Revvity Signals Software Speakers
Marie Jué: Field Application Scientist, Revvity
Marie is a Chemical Engineer specialized in Formulation Chemistry. She worked in R&D formulation laboratories. First at Axalta Coating Systems where she learned basics of formulation chemistry in Industrial Coating R&D Team. She then expanded her knowledge joining Sherwin Williams R&D team. Today Marie uses her background to easily understand formulator’s needs and promote Signals Notebook capabilities in order to facilitate scientist’s daily life.
Anne Ballard, Signals Notebook Product Manager– Customer Success, Revvity
Anne Ballard is the product manager for Signals Notebook spearheading the Continuous Improvement Program, focusing on Customer requested enhancements to core functionality. Prior to her work at Revvity Signals, she worked building software solutions to connect laboratories with their clinical clients. She has a background in molecular biology and genetics and earned a Masters in biology from American University.
Revolutionizing Inventory Management: Signals Notebook and Success Stories at EMD Electronics
Join us for an insightful webinar exploring the cutting-edge inventory management strategies implemented at EMD Electronics. This session will provide a comprehensive look at how modern inventory systems and methodologies are transforming business operations and enhancing efficiency.
Our agenda includes:
- Latest Revvity Signals Inventory Features Jen Miller will review the most recently released features of Inventory, showcasing the latest tools and capabilities to optimize inventory management.
- Signals Implementation at EMD Electronics: An IT and Business Perspective A key representative Lara Dabrowski from EMD Electronics will share their experience implementing Signals, highlighting integrating IT solutions with business objectives for optimal inventory management.
- Real-World Impact: Inventory Management in Action, Richard Ho from EMD Electronics, will share how Inventory has made life easier for him and his team. He'll discuss his experiences with reconciliation processes and provide insights into how Inventory has improved their numerous responsibilities.
This webinar is ideal for professionals looking to enhance their inventory processes, harness cutting-edge technology, and drive operational excellence. Don't miss this opportunity to learn from industry experts and engage in meaningful discussions about the future of inventory management.
Join us for this informative webinar and discover how you can apply industry-leading strategies to your own organization.
Register now and secure your spot! We look forward to seeing you there!
Revvity Signals Software Speakers
Lara Dabrowski - Senior Business Process Architect & Solution Expert at Merck KGaA
Lara Dabrowski is a chemical engineer, holding a Master’s degree (Dipl.-Ing.). With over 13 years of experience in pigments/coatings innovation, she has led research and customer projects, optimized lab processes, and supported IT projects. Her expertise extends to R&D, Evonik customer activities, and research on conductive materials from Ciba, Switzerland. For the past 2 years, Lara has been working at Merck KGaA as a Senior BPA and SME for Signals Notebook within IT for R&D, where she focuses on the propagation and enhancement of SNB across multiple sites. Her expertise also includes lab automation, safety features, and regulatory compliance.
Jennifer Miller - Sr. Product Leader at Revvity Signals
Jennifer is a Senior Product Manager at Revvity Signals and has responsibility for Signals Notebook Inventory, Materials and Signals Suite. Prior to Revvity Signals she worked in the in the pharmaceutical industry for over 15 years in the development of small molecule drugs for cancer and inflammation. She holds a degree in in Molecular, Cellular and Developmental Biology.
1. Transforming in vivo research with Signals Research Suite
Sunetra Ray, Ph.D. - In vivo Lead Product Manager
Traditionally, preclinical in vivo studies have relied on manual methods like spreadsheets, emails, and isolated tools, resulting in fragmented data management. Furthermore, the intricate workflows and the need for skilled personnel to collect and interpret data have continued to hinder automation efforts. The in vivo capability in Signals Research Suite transforms these processes by enabling seamless end-to-end study workflows. By integrating with Electronic Lab Notebooks (ELN) and advanced data analysis tools, this digital platform overcomes the constraints of traditional approaches, streamlining research procedures and significantly improving the precision and efficiency of in vivo studies.
2. Successfully analyzing screening assays capturing single to multiple and high-dimensional readouts
Eduardo Gonzalez-Couto, Ph.D. - In vitro Lead Product Manager
Modern screening assays take advantage of the recent advances in instrumentation allowing to capture multiple readouts simultaneously. Together, these readouts can better capture the complexity of the underlying biology like in the context of flow cytometry, gene expression or even from images with high content screening. However, harnessing the benefits of these instrumentation advances requires advanced analysis and visualization software. Signals Research Suite covers all the dimensions of innovative screening approaches at scale to interpret better and faster your assay results.
3. Unlocking Hidden Gems: Why Public Datasets are a Treasure Trove
Alexandra Vamvakidou, Ph.D. - Field Application Scientist, Leanna Shuster, M.A., Field Application Scientist
In today’s data-driven world, organizations increasingly rely on data analytics to gain a competitive edge. Generating data is time-consuming and costly, therefore leveraging publicly available datasets to correlate with internal data allows scientific groups to increase their efficiency and improve their overall data scope. Researchers acknowledge the benefits of connecting multiple data sources to improve the precision of their findings and shape future research directions, challenging existing perceptions of scientific knowledge. This presentation will explore the art of extracting meaningful insights from complex scientific data, including how to use Signals to reach meaningful conclusions by leveraging large, publicly available datasets, with examples from PubChem. We will use Spotfire and the built-in chemical intelligence of Signals Research Suite to explore such data.
What you will learn:
- The importance and benefits of leveraging publicly available datasets in scientific research and how to extract meaningful insights from complex scientific data using Signals Research Suite
- How Signals Research Suite facilitates analysis and visualization of in vitro screening techniques employing multi-and high-dimensional data acquisition for better and faster assay interpretation.
- The benefits of Signals Research Suite and its advanced data analysis capabilities to streamline in vivo research procedures and improve the precision and efficiency of in vivo studies.
Signals Research Suite Speakers
Sunetra Ray, P.h.D.
In vivo Lead Product Manager
Sunetra Ray is Lead Product Manager for in vivo informatics solutions at Revvity Signals. She has a PhD in Molecular Pharmacology from UCLA, with 4+ years of industry experience in preclinical PK/PD studies, drug discovery and translational research. Sunetra's has broad experience in both in vitro and in vivo with extensive experience conducting in vivo studies in animal models of cancer, infectious diseases, and inflammation.
Eduardo Gonzalez-Couto, Ph.D
In vitro Lead Product Manager
Dr. Gonzalez-Couto is currently responsible for the core screening capabilities of Signals VitroVivo and formerly was product manager for translational medicine, bioinformatics products strategist & manager at R. Previously, he was CSO at Integromics and has more than 25 years of professional experience in bioinformatics gained at GlaxoWellcome, GeneProt, and Siena Biotech. He received his Ph.D. in Molecular Genetics after obtaining a Master in Molecular Biology and graduating in Biochemistry at the University of Geneva, Switzerland.
Alexandra Vamvakidou, Ph.D
Field Application Scientist
Alexandra holds a Master’s degree in Electrical and Computer Engineering from The National Technical University of Athens, Greece, and earned a Ph.D. in Biomedical Engineering from Drexel University. As a R Principal Field application scientist, she works closely with researchers to identify their challenges and propose solutions.
Leanna Shuster, M.A.
Field Application Scientist
Leanna Shuster graduated from Scripps College in Claremont, CA with a Bachelors degree in Chemistry and received a Masters of Science in Organic Chemistry from UCLA. She moved to the Philadelphia area in 2006 where she began work with GlaxoSmithKline as a medicinal chemist. During her 15 years at GSK, Leanna’s drug discovery areas of focus included High Throughput Chemistry, Green Chemistry, and Oncology therapeutics, while also building skills in analytics, data science, and informatics. She joined Revvity Signals as a Field Applications Scientist in 2022, where she supports a range of scientific software solutions.
Driving Innovation in Signals Notebook: Eli Lilly and Company's Success Story with External Actions and APIs
Join us for an exclusive webinar where we showcase how industry leader Eli Lilly has successfully leveraged external actions and APIs to revolutionize their Signals Notebook workflows. Discover the power of these tools and learn how you can apply similar strategies to optimize your own data management processes.
In this webinar, our expert speakers will guide you through:
- The fundamentals of external actions and APIs, and their role in streamlining integration processes
- Real-world examples and use cases from Eli Lilly’s implementation
- Best practices for implementing external actions and leveraging APIs for reporting and dashboards
- Strategies for seamless integration with registration systems and maintaining GXP compliance
Throughout the webinar, you'll gain valuable insights, lessons learned, and actionable takeaways from Eli Lilly's experience. Don't miss this opportunity to learn how external actions and APIs can transform your Signals Notebook workflows and unlock the full potential of your data management processes.
Join us for this informative webinar and discover how you can apply industry-leading strategies to your own organization.
Register now and secure your spot! We look forward to seeing you there!
Revvity Signals Software Speakers
Douglas R Stack - R&D IT, Lilly Research Laboratories
Doug Stack is a (fairly) recent addition to R&D IT. He has been with Lilly for 30 years, with the first 28 spent in Discovery Chemistry as an Organic Medicinal Chemist. During that time, he contributed to projects across all therapeutic areas, used automation extensively and served as the Business SME for electronic notebooks.
Doug brought his lab knowledge to the IT area in 2022 and made immediate impact by leading a fast and successful implementation of Signals Notebook Discovery-wide. He continues to support multiple scientific software solutions and is actively engaged in improving the Signals offering for his customers.
Alycia Hargraves - IT Manager at Eli Lilly
Alycia Hargraves is an IT Manager at Eli Lilly, supporting several electronic lab notebooks (eLN) as a technical subject matter expert (TSME) for the Lilly Research Laboratories. She has been with Eli Lilly for 8 years, managing the lifecycle of more than 7 Laboratory Information Systems (LIMS) across the Research and Manufacturing & Quality organizations. Prior to Lilly, she worked as a Software Engineer, building LIMS for laboratories across the globe.
Alycia has a Bachelor’s in Computer Science from Florida A&M University. She enjoys playing board/video games with her family, trying new foods and drawing in her spare time.
Colin Fyffe - Product Manager, Integrations and Interfaces, Revvity
Colin joined Revvity in May of this year to expand our developer relationships. He is creating customer-friendly documentation, defining best practices, and providing practical examples to customers.
Colin spent a decade as a software engineer for PayPal before moving into product management with an ISP.
Enhancing Collaboration between
Sponsors and Contract Partners in Drug Discovery
Most contemporary drug discovery companies (Sponsors) outsource some (or all) drug development to external contract partners, e.g., Contract Research Organizations (CROs) and/or Contract Development and Manufacturing Organizations (CDMOs). Communication between Sponsor and Contract organization is largely done via e-mail and poorly structured Excel reports which is a highly manual, inefficient, and error prone process. Additionally, Sponsors of contracted work struggle with a common set of problems and challenges including:
- Prioritizing and communicating the work to the CRO
- Onboarding and offboarding CRO resources
- Tracking the work at the CRO
- Masking proprietary information from the CRO to preserve the sponsors intellectual property
- Integrating the data from the CRO into the corporate data management systems
Historically each sponsor has been isolated to solve these problems on their own, costing time and money, but today we announce a new capability being delivered in 2024 by Revvity Signals that adds fit-for-purpose CRO collaboration capabilities to Signals Notebook and Signals Research Suite. This cutting-edge new product will leverage the Signals Platform and solve the common problems plaguing the standard sponsor-CRO interactions.
What you will learn:
- Gain insights into the administration, collaboration, IP protection, and project management challenges facing Biopharmaceutical sponsors when they externalize drug discovery research.
- Learn how Signals Synergy, a new solution from Revvity Signals, redefines collaboration between biopharmaceutical sponsors and contract partners.
- Get a glimpse of the key capabilities inside Signals Synergy.
Signals Research Suite Speakers
Heather Hayes
Signals Synergy Product Leader, Revvity Signals
Heather Hayes received her Bachelor of Engineering from Vanderbilt University, where she graduated Valedictorian from the School of Engineering. After completing her PhD in Biomedical Engineering at Georgia Institute of Technology focused on neuropharmacology and sensory modulation, she led translational studies and clinical trials for neuroplasticity-promoting therapeutics for spinal cord injury. Since joining the biotech industry, Heather has over 7 years of experience in the development and product management of high throughput screening instrumentation and stem cell disease modeling. Heather joined Revvity in 2022 to lead our initiative to enable and accelerate Sponsor-CRO collaboration workflows in the Signals Platform. She now serves as Product Leader for Signals Synergy
Chris Stumpf
Marketing Programming Manager
Chris Stumpf is a Senior Principal Marketing Professional responsible for Marketing Programs at Revvity Signals. Chris has over 20 years of experience in the Analytical Instrumentation and Informatics industry spanning Pharmaceuticals & Life Sciences to Chemicals & Materials. He has a Ph.D. in Analytical Chemistry and Mass Spectrometry from Purdue University.
Revolutionize your formulation science workflows with Signals Notebook
Revolutionize your formulation science workflows with Signals Notebook, a powerful tool designed to support both upstream and downstream processes in the pharmaceutical and industrial chemistry sectors. Our team of experts is excited to show you how Signals Notebook can help you leverage formulation science data for enhanced analytics, ultimately streamlining your research efforts.
- Streamline data capture, organization, and experiment design
- Integrate upstream and downstream formulation science workflows
- Enable real-time collaboration and seamless data sharing
- Leverage formulation science data for enhanced analytics and predictive modeling
Join us for an insightful webinar and discover how Signals Notebook can transform your workflows. Don't miss this opportunity to witness the future of formulation science and optimize your experimental designs.
Revvity Signals Software Speakers
Philip Skinner - Product Manager, Signals Notebook
Philip is a Spotfire evangelist, specifically in the lifescience and chemistry communities, and is delighted to bring his experience and passion to provide consulting to customers of Revvity Signals who are using or considering using Spotfire. Prior to joining Revvity, Philip spent a decade working as a medicinal chemist at a San Diego based biotech, progressing GPCR ligands into clinical development for metabolic diseases. Philip holds a PhD in Chemistry from the University of Durham and completed postdoctoral studies at the ETH in Zurich.
Marie Jue - Field Application Scientist
Marie is a Chemical Engineer specialized in Formulation Chemistry. She worked in R&D formulation laboratories. First at Axalta Coating Systems where she learned basics of formulation chemistry in Industrial Coating R&D Team. She then expanded her knowledge joining Sherwin Williams R&D team. Today Marie uses her background to easily understand formulator’s needs and promote Signals Notebook capabilities in order to facilitate scientist’s daily life.
Agenda: Navigating T-Cell Dynamics: Harnessing FACS Analysis through Signals Notebook
T-cell immunotherapies like CAR-T and TCRs are transforming cancer and disease treatment, but realizing their full potential requires overcoming challenges in engineering optimized therapeutic cells.
In this webinar, discover:
- The evolving therapeutic applications and benefits of engineered T-cells
- Key obstacles around T-cell isolation, proliferation, and data organization
- Signals support screening compounds against T-cells
- How FACS analysis provides critical insights for advancement
Within Signals Notebook, attendees will discover an integrated platform to strategically organize experiments, capture data, and collaborate across teams. Attendees will learn strategic workflows to harness tools like FACS to advance their immunotherapy or T-cell engineering initiatives aimed at bringing more targeted, potent, and durable treatments to patients.
Revvity Signals Software Speakers
Zev Wisotsky - Sr. Principal Marketing Manager for Biologics
Zev is a Sr. Principal Marketing Manager for Biologics in the Signals Suite. His scientific training and research background includes neuroscience, biochemistry, molecular biology, and drug discovery. He has spent 7+ years in software in go-to-market teams across industries with a heavy focus on biopharma/biotech R&D.
Harnessing the Power of Antibody Drug Conjugates:
How the Signals™ Research Suite Advances Multi-Modal Drug Development
The Signals™ Research Suite is the first integrated informatics platform purpose-built to accelerate multi-modal drug development like ADCs and is composed of a trio of scientific software applications:
- Signals™ Notebook: The premier cloud-based electronic lab notebook that facilitates creation and communication about molecules of interest via hierarchical editing language for macromolecules (HELM), powered Chemdraw®.
- Signals™ VitroVivo: For data analysis, visualization, and curve fitting bioassay results for standardized and consistent results, powered by Spotfire®.
- Signals™ Inventa: Enabling multi-assay or multi-study comparison, powered by Spotfire, with the ability to find the best candidate to move forward, accelerating decision making. Researchers gain better visibility into ADC candidate profiling and can quickly determine structure-activity and structure-property relationships across modalities to select optimal conjugation sites and pairings.
Attendees will gain insights into the latest trends and challenges in ADC development, informed by recent research and advancements in the field. The presentation will also emphasize the importance of integrating various data types and sources in the ADC development process, showcasing how the Signals Research Suite facilitates this integration, thereby driving more efficient, safer drug development.
Signals Research Suite Speakers
Zev Wisotsky
Sr. Principal Marketing Manager for Biologics in the Signals Research Suite
Zev attended the University of California, Santa Cruz with a focus on molecular and cellular biology. He obtained his Ph.D. at the University of California, Riverside for Neuroscience where he worked on taste detection from molecular mechanism to behavioral outcomes in fruit flies. Subsequently Zev joined startup companies with the focus to support scientists getting their science done more efficiently. He has worked within pre-sales teams to discover, consult, and deliver software solutions that meet customer needs both scientifically and technically. Today he is a Revvity Senior Principle Marketing Manager for Biologics in the Signals Suite.
Agenda: Highlighting Our Top 2023 Enhancements
Secure your access to our event showcasing last year’s most impactful platform upgrades, designed to reduce complexity and drive productivity. In this session, explore innovations and elevated workflows including:
- New Modality Support - Enhanced HELM functionality unlocks workflows for cutting-edge science.
- Inventory Intelligence- Leverage smarter tools to empower seamless decrementing, transferring, and streamlined requesting.
- GxP Compliance – Supporting more rigid documentation and workflows for controlled data entry and quality checks.
- Expanded Connectivity - Through robust APIs, rapidly augment integrations with complementary systems.
- Intuitive Experiences - Numerous enhancements focused on usability and instinctive interactions upgrade daily efforts.
We eagerly anticipate demonstrating our premier 2023 enhancements – claim your spot now for this focused overview of essential upgrades that simplify, expedite, and empower critical workflows.
Revvity Signals Software Speakers
Michelle Laussen – Signals Notebook Product Lead, Revvity Signals
Michelle current leads the talented Product Management team for Signals Notebook, focusing on establishing the product strategy and driving customer success. She has a blend of professional experience from her work as a bench scientist, leadership roles in the implementation of scientific software applications, and the marketing of enterprise informatics software. Previously she worked as a scientist in cellular assay development, applying informatics daily. She received a Master’s in Biochemistry and Molecular Biology from Boston University.
Anne Ballard, Signals Notebook Product Manager – Customer Success, Revvity Signals
Anne Ballard is the product manager for Signals Notebook spearheading the Continuous Improvement Program, focusing on Customer requested enhancements to core functionality. Prior to her work at Revvity Signals, she worked building software solutions to connect laboratories with their clinical clients. She has a background in molecular biology and genetics and earned a Masters in biology from American University.